Drugs /
ibuprofen
Overview
Clinical Trials
Ibuprofen has been investigated in 1 clinical trial, of which 1 is open and 0 are closed. Of the trial investigating ibuprofen, 1 is phase 1 (1 open).
IL3RA Expression is the most frequent biomarker inclusion criterion for ibuprofen clinical trials.
Acute lymphoblastic leukemia and hematopoietic and lymphoid malignancy are the most common diseases being investigated in ibuprofen clinical trials [2].
Drug Details
References
1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/. [2018-07-30] [2018-08-02].
2. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.